Immediate Impact
63 standout
Citing Papers
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Extracellular vesicles in tumor immunity: mechanisms and novel insights
2025 Standout
Works of Qunyi Guo being referenced
CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2020
A phase I trial using CD19 CAR-T expressing PD-1/CD28 chimeric switch-receptor for refractory or relapsed B-cell lymphoma.
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Qunyi Guo | 150 | 129 | 35 | 57 | 26 | 293 | |
| Jingyu Xiang | 132 | 174 | 15 | 76 | 21 | 332 | |
| Kyriaki Tzogani | 140 | 143 | 29 | 35 | 16 | 329 | |
| Hossein Saeedi | 110 | 134 | 20 | 78 | 19 | 295 | |
| Guang Yang | 84 | 138 | 32 | 65 | 36 | 305 | |
| Gregory M. Cresswell | 79 | 111 | 70 | 106 | 16 | 329 | |
| Hanfei Guo | 113 | 128 | 76 | 35 | 20 | 308 | |
| Hitomi Hosoya | 88 | 69 | 28 | 35 | 22 | 232 | |
| Gunjan Dagar | 134 | 116 | 36 | 54 | 15 | 242 | |
| Justyna Czapla | 92 | 130 | 21 | 97 | 21 | 333 | |
| Zhen Jin | 165 | 110 | 13 | 61 | 17 | 302 |
All Works
Loading papers...